
Order NO. D161049
兔抗NQO1多克隆抗体




英文名 | Anti-NQO1 rabbit polyclonal antibody | ||
别名 | DTD, QR1, DHQU, DIA4, NMOR1, NMORI | ||
相关类别 | 一抗 | 储存 | 冷冻(-20℃) |
宿主 | Rabbit | 反应种属 | Human, Mouse, Rat |
标记物 | Unconjugate | 克隆类型 | rabbit polyclonal |
抗原 | NQO1 | ||
编 号 | 包装 | 库存 | 目录价(¥) | 您的价格(¥) | 数 量 |
D161049-0025 | 25 ul | 现货 |
![]() |
![]() |
![]() |
D161049-0100 | 100 ul | 现货 |
![]() |
![]() |
![]() |
D161049-0200 | 200 ul | 现货 |
![]() |
![]() |
![]() |
属性
Background: | This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. |
Applications: | ELISA, WB, IHC |
Name of antibody: | NQO1 |
Immunogen: | Synthetic peptide of human NQO1 |
Full name: | NAD(P)H quinone dehydrogenase 1 |
Synonyms: | DTD; QR1; DHQU; DIA4; NMOR1; NMORI |
SwissProt: | P15559 |
ELISA Recommended dilution: | 5000-10000 |
IHC positive control: | Human lung cancer and Human colorectal cancer |
IHC Recommend dilution: | 50-200 |
WB Predicted band size: | 31 kDa |
WB Positive control: | Hela, MCF7, A549, HepG2 cell lysates |
WB Recommended dilution: | 500-2000 |